SomnoMedSOMNF 49 OCF Margin % is 6.83% as of Dec. 2025. GuruFocus rates SOMNF with a GF Score™ of 49/100 and a GF Value™ of $0.33 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, SomnoMed ranks better than 51.16% on this metric.
The historical rank and industry rank for SomnoMed's OCF Margin % or its related term are showing as below:
SOMNF'
s OCF Margin % Range Over the Past 10 Years
Min: -14.89 Med: -1.04 Max: 9.06
Current: 6.63
During the past 13 years, the highest OCF Margin % of SomnoMed was 9.06%. The lowest was -14.89%. And the median was -1.04%.
SOMNF's OCF Margin % is ranked better than 51.16% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs SOMNF: 6.63
SomnoMed OCF Margin % Related Terms
SomnoMed OCF Margin % Historical Data
* Premium members only.
The historical data trend for SomnoMed's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SomnoMed's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SomnoMed OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SomnoMed's OCF Margin % distribution charts can be found below:
* The bar in red indicates where SomnoMed's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SomnoMed (SOMNF) has a OCF Margin % of 6.83% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SomnoMed and its competitors. According to the industry distribution chart, SomnoMed ranks #399 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 48.8%.
Is SomnoMed's OCF Margin % too high?
SomnoMed's current OCF Margin % is 6.83%. The Medical Devices & Instruments industry median OCF Margin % is 5.82. SomnoMed's value of 6.83% is 17.4% above this industry median. Based on the distribution chart, SomnoMed ranks #399 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SomnoMed has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SomnoMed's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SomnoMed ranks #399 out of 817 companies for OCF Margin %. This puts SomnoMed in the upper half of its industry. The industry median OCF Margin % is 5.82. SomnoMed's value of 6.83% is 17.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SomnoMed's current OCF Margin % of 6.83% is 17.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SomnoMed and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SomnoMed's current OCF Margin % is 6.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SomnoMed stock overvalued right now?
Based on GuruFocus' analysis, SomnoMed (SOMNF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.33, compared to a current price of $0.45 — trading 35.7% above its estimated fair value. The current OCF Margin % is 6.83% and 17.4% above the Medical Devices & Instruments industry median of 5.82. SomnoMed's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For SomnoMed (SOMNF), the current OCF Margin % is 6.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SomnoMed (SOMNF) Overvalued in 2026?
Based on GuruFocus' analysis, SomnoMed stock appears to be overvalued.
The current stock price of $0.45 is trading 35.7% above its estimated GF Value™ of $0.33.
GuruFocus considers SomnoMed to be Significantly Overvalued.
Key valuation signals for SOMNF:
OCF Margin %: 6.83%
GF Value™: $0.33 vs. price of $0.45 (35.7% above fair value)
Industry Position: 17.4% above the Medical Devices & Instruments median (#399 of 817)
No single metric tells the full story. See the SOMNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.
49GF Score
Get the complete analysis for SOMNF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOMNF has been successfully added to your 
